AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Gutierrez, R. L.
Right arrow Articles by Lehman, C. D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutierrez, R. L.
Right arrow Articles by Lehman, C. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.08.1983
AJR 2009; 193:994-1000
© American Roentgen Ray Society


Original Research

BI-RADS Lesion Characteristics Predict Likelihood of Malignancy in Breast MRI for Masses But Not for Nonmasslike Enhancement

Robert L. Gutierrez1,2, Wendy B. DeMartini1,2, Peter R. Eby1,2, Brenda F. Kurland3, Sue Peacock1,2 and Constance D. Lehman1,2

1 Department of Radiology, University of Washington Medical Center, University of Washington, Seattle, WA.
2 Seattle Cancer Care Alliance, 825 Eastlake Ave. E, G3-200, Seattle, WA 98109.
3 Fred Hutchinson Cancer Research Center, Seattle, WA.

OBJECTIVE. The purpose of our study was to evaluate the predictive features of BI-RADS lesion characteristics and the risk of malignancy for mammographically and clinically occult lesions detected initially on breast MRI.

MATERIALS AND METHODS. We reviewed 1,523 consecutive breast MRI examinations performed from January 1, 2003, to June 30, 2005, to identify all lesions initially detected on MRI and assessed as BI-RADS 4 or 5 for which the patient underwent subsequent imaging-guided needle or excisional biopsy. BI-RADS lesion features were recorded for each case, and the risk of malignancy was assessed using generalized estimating equations. Separate multivariate models were constructed for lesions classified as masses.

RESULTS. Included in the analysis were 258 suspicious lesions in 196 women. Among all lesions, those of 1 cm or greater were significantly more often malignant (50/147, 34%) than lesions of less than 1 cm (22/111, 20%; odds ratio, 2.09; 95% CI, 1.13–3.83). For masses, size, BI-RADS margin, and enhancement pattern predicted malignancy. In multivariate analysis of combinations of features, masses of 1 cm or greater with heterogeneous enhancement and irregular margins had a 68% probability of malignancy. Masses of 1 cm or greater with smooth margins and homogeneous enhancement had the lowest predicted probability of malignancy of 3%. BI-RADS descriptors and size were not significant predictors of malignancy for nonmasslike enhancement (NMLE).

CONCLUSION. Combinations of BI-RADS lesion descriptors can predict the probability of malignancy for breast MRI masses but not for NMLE. If our model is validated, masses with a low probability of malignancy may be eligible for short-interval follow-up rather than biopsy. Further research focused on predictive features of NMLE is needed.

Keywords: BI-RADS • breast • masses • morphology • MRI


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Roentgen Ray Society.